| Glucose Reduction by Early Acarbose Treatment in Basal Insulin (NCT00970528) | Bayer | 2009-11-01 |
| Two Pieces of Fruit to Type 2 Diabetics? (NCT01010594) | Hospitalsenheden Vest | 2009-11-01 |
| Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes Mellitus (NCT01058889) | Medical University of Vienna | 2009-11-01 |
| Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug Treatment (NCT01022762) | Novo Nordisk A/S | 2009-11-01 |
| Linagliptin 2.5 mg Twice Daily Versus 5 mg Once Daily as add-on Therapy to Twice Daily Metformin in Type 2 Diabetes (NCT01012037) | Boehringer Ingelheim | 2009-11-01 |
| Beta Cell Relieving and Cardiovascular Protective Effects of LANTUS Treatment in Type 2 Diabetes Patients (NCT01206712) | ikfe-CRO GmbH | 2009-11-01 |
| Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy (NCT01079325) | Sangamo Therapeutics | 2009-11-01 |
| A 2-Part Trial in Subjects With Type 2 Diabetes and in Healthy Subjects to Evaluate GSK1614235, a New Glucose Lowering Drug to Treat Type 2 Diabetes (NCT00976261) | GlaxoSmithKline | 2009-10-17 |
| Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study (NCT01007266) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2009-10-09 |
| Preventing Diabetic Osteoporosis With Exercise (NCT03930758) | University of Michigan | 2009-10-08 |
| Self Titration With Apidra to Reach Target Study (START) (NCT01013571) | Sanofi | 2009-10-01 |
| Restoration of Beta Cell Function and Cardiovascular Parameters in Relation to Adipoinsular and Enteroinsular Axes After Gastric Bypass Surgery (NCT01271062) | Cantonal Hospital of St. Gallen | 2009-10-01 |
| A Study of LY2189265 in Japanese Patients With Type 2 Diabetes (NCT01001104) | Eli Lilly and Company | 2009-10-01 |
| Influence of Acupuncture to Ocular Microcirculation in Patients With Diabetes Mellitus (NCT01022177) | Technische Universität Dresden | 2009-10-01 |
| Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone (NCT00996658) | Boehringer Ingelheim | 2009-10-01 |
| A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics (NCT00993304) | Novo Nordisk A/S | 2009-10-01 |
| Increasing Vitamin Intake and Physical Activity (NCT00985179) | Freie Universität Berlin | 2009-10-01 |
| Efficacy of DLBS-32 in Subjects With Type-II Diabetes Mellitus (NCT01005069) | Dexa Medica Group | 2009-10-01 |
| Improvement of a Physically Active Lifestyle (NCT00979719) | Freie Universität Berlin | 2009-10-01 |
| An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus (NCT01001611) | Chong Kun Dang Pharmaceutical | 2009-10-01 |
| Malignancy Meta Analysis for BRL49653 (NCT01195259) | GlaxoSmithKline | 2009-10-01 |
| Online Program Assisting Lifestyle Changes (Asterix 1.0 & Obelix 2.0) (NCT00986375) | Freie Universität Berlin | 2009-10-01 |
| Laparoscopic Gastric Bypass for Type 2 Diabetes Mellitus With Body Mass Index (BMI) < 35 (NCT00999050) | Weill Medical College of Cornell University | 2009-10-01 |
| Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention (NCT03792685) | Medical University of Bialystok | 2009-09-24 |
| Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity (NCT00992797) | University Hospital, Aker | 2009-09-01 |
| Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus (NCT00957268) | Takeda | 2009-09-01 |
| Insulin Resistance as Primary Pathogenesis in Newly Diagnosed, Drug naïve Type 2 Diabetes Patients in Korea (NCT01154244) | GlaxoSmithKline | 2009-09-01 |
| Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes (NCT00982644) | Novo Nordisk A/S | 2009-09-01 |
| CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride (NCT00968812) | Janssen Research & Development, LLC | 2009-09-01 |
| Physical Activity for a Long and Healthy Life (NCT01430143) | University of Copenhagen | 2009-09-01 |
| A Study of Insulin Lispro Mix in Type 2 Diabetic Asian Patients (NCT00971997) | Eli Lilly and Company | 2009-09-01 |
| Phenotypic and Genetic Correlates of Diabetes (Non-Type 1) in Young Non-Obese Asian Indians in North India and A Study to Evaluate the Efficacy of Sitagliptin (DPP-4 Inhibitor) in a Sub-group of the Study Population (NCT00964184) | Diabetes Foundation, India | 2009-09-01 |
| Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome (NCT00968708) | Takeda | 2009-09-01 |
| A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine (NCT00976391) | GlaxoSmithKline | 2009-09-01 |
| Impact of Pharmaceutical Care in Diabetics Patients (NCT01580904) | Universidade Estadual da Paraiba | 2009-09-01 |
| Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes (NCT00972283) | Novo Nordisk A/S | 2009-09-01 |
| Adipose Tissue Function After Pancreas Transplantation (NCT01729130) | The University of Texas Medical Branch, Galveston | 2009-09-01 |
| Clinical Study to Assess the Safety and Pharmacokinetics of SRT2104 in Type 2 Diabetic Human Subjects (NCT00937326) | Sirtris, a GSK Company | 2009-08-19 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics (NCT01013766) | GlaxoSmithKline | 2009-08-13 |
| A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects. (NCT00938158) | GlaxoSmithKline | 2009-08-05 |
| Regional Fat Depots and Insulin Resistance (NCT01336777) | Stanford University | 2009-08-01 |
| Risk of Acute Kidney Injury Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments (NCT01377935) | AstraZeneca | 2009-08-01 |
| Metabolic Effects of a Pre-meal Protein Drink With or Without Added Amino Acids at a Subsequent Composite Meal (NCT01586780) | Lund University | 2009-08-01 |
| Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes (NCT00954447) | Boehringer Ingelheim | 2009-08-01 |
| Risk of Hospitalization for Severe Hypersensitivity (Including Severe Skin Reactions) in Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments (NCT01086319) | AstraZeneca | 2009-08-01 |
| Lancing Device Comparison Study (NCT01740778) | Facet Technologies | 2009-08-01 |
| Endotoxin and Intestinal Flora Before and After Gastric Bypass or Banding in Diabetics (NCT00960765) | CPL Associates | 2009-08-01 |
| Sleeve Gastrectomy Versus Medical Management for Remission of Diabetes in Mild to Moderately Obese Patients (NCT00965302) | 59th Medical Wing | 2009-08-01 |
| The Effects of Omega-3 Fatty Acid (OMACOR) on the Low-density Lipoprotein (LDL) Sub-fraction in Type 2 Diabetic Patients (NCT00758927) | Inje University | 2009-07-01 |
| Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients (NCT00965549) | Sanofi | 2009-07-01 |
| Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes Patients (NCT00957060) | Sanofi | 2009-07-01 |
| Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old (NCT00843232) | University of Campinas, Brazil | 2009-07-01 |
| Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary Care (NCT00950534) | Sanofi | 2009-07-01 |
| Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure (NCT00799435) | Baylor College of Medicine | 2009-07-01 |
| Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment (NCT00949442) | Sanofi | 2009-07-01 |
| DREAM Project Community Health Worker Intervention (NCT02041598) | NYU Langone Health | 2009-07-01 |
| Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM) (NCT00916357) | Halozyme Therapeutics | 2009-07-01 |
| Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes Mellitus (NCT02224118) | Janssen Pharmaceutical K.K. | 2009-07-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus (NCT00946972) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-07-01 |
| Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment (NCT01907113) | Boehringer Ingelheim | 2009-07-01 |
| Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors (NCT00928889) | Novartis Pharmaceuticals | 2009-07-01 |
| Exercise and Glycemic Control in Type 2 Diabetes (NCT00945165) | Maastricht University Medical Center | 2009-07-01 |
| A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (NCT01119846) | GlaxoSmithKline | 2009-06-05 |
| A Study of RO5095932 in Patients With Type 2 Diabetes Mellitus (NCT00961909) | Hoffmann-La Roche | 2009-06-01 |
| The Aging Endocrine Pancreas: Characterization of the Entero-insular Axis Physiology in the Elderly (NCT00843479) | University of Campinas, Brazil | 2009-06-01 |
| Treatment of Type 2 Diabetes With Linagliptin 2.5 mg Bid + Metformin 500 or 1000 mg Bid and Metformin 1000 mg Bid (NCT00915772) | Boehringer Ingelheim | 2009-06-01 |
| Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles (NCT00928057) | Becton, Dickinson and Company | 2009-06-01 |
| Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2 (NCT00931372) | Sanofi | 2009-06-01 |
| Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial (NCT00851903) | Sanofi | 2009-06-01 |
| Interleukin-1 Receptor Antagonist and Insulin Sensitivity (NCT00928876) | Radboud University Medical Center | 2009-06-01 |
| Safety, Tolerability and Pharmacokinetics Study of EGT0001474 in Subjects With Type 2 Diabetes (NCT00924053) | Theracos | 2009-06-01 |
| Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE) (NCT00790517) | Kaiser Permanente | 2009-06-01 |
| Pharmacokinetics and Pharmacodynamics Trial With Linagliptin (BI 1356) 5mg in African American Type 2 Diabetic Patients (NCT00935220) | Boehringer Ingelheim | 2009-06-01 |
| Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients (NCT00941369) | Sanofi | 2009-06-01 |
| A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese Subjects (NCT00897169) | Novo Nordisk A/S | 2009-06-01 |
| Aerobic Training, Aerobic-resistance Training and Glucose Profile (CGMS) in Type 2 Diabetes (NCT00887094) | Hospital de Clinicas de Porto Alegre | 2009-06-01 |
| A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment (NCT00933972) | Hoffmann-La Roche | 2009-06-01 |
| Natural History of Autoimmune Diabetes and Its Complications (NCT00896610) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2009-05-13 |
| Safety of NovoMix® 30 or Levemir® for Treatment of Type 2 Diabetics in Macedonia (NCT00842894) | Novo Nordisk A/S | 2009-05-01 |
| Observatory on Elderly Patients "Les S.AGES" (NCT01065909) | Sanofi | 2009-05-01 |
| A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes (NCT00909597) | Hoffmann-La Roche | 2009-05-01 |
| Effect of Insulin Detemir and Insulin Glargine on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00909480) | Novo Nordisk A/S | 2009-05-01 |
| Skin and Retina Microvascular Endothelial Function in Healthy, Insulin Resistant and Type 2 Diabetic Subjects (NCT01241370) | ELAB-Logistics | 2009-05-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Malaysia (NCT00877526) | Novo Nordisk A/S | 2009-05-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Taiwan (NCT00887874) | Novo Nordisk A/S | 2009-05-01 |
| GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS) (NCT00905255) | Sanofi | 2009-05-01 |
| Thiazolidinedione Intervention With Vitamin D Evaluation (NCT00879970) | GlaxoSmithKline | 2009-05-01 |
| A Randomized Trial of Diabetes Prevention Through Lifestyle Change in India (NCT01283308) | Emory University | 2009-05-01 |
| A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Korea (NCT00918151) | Novo Nordisk A/S | 2009-05-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus (NCT00871507) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-04-01 |
| Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment (NCT00795600) | Novo Nordisk A/S | 2009-04-01 |
| An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries (NCT00842192) | Novo Nordisk A/S | 2009-04-01 |
| Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients (NCT00900146) | Novartis | 2009-04-01 |
| Evaluation of a Computer-Based, Self-Management Tool for People With Type 2 Diabetes (NCT00877851) | Queen's University, Belfast | 2009-04-01 |
| Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients (NCT00834262) | Novo Nordisk A/S | 2009-04-01 |
| Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM) (NCT00908921) | Sanofi | 2009-04-01 |
| 4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM) (NCT00885118) | Boehringer Ingelheim | 2009-04-01 |
| A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin (NCT00823680) | Hoffmann-La Roche | 2009-04-01 |
| Mood and Diabetes Empowerment & Improvement Training (NCT02010684) | University of California, Los Angeles | 2009-04-01 |
| A Survey to Evaluate Diabetes Management, Control, Complications and Psychosocial Aspects of Diabetic Patients in Philippines (NCT00874159) | Novo Nordisk A/S | 2009-04-01 |